Regulation of Transforming Growth Factor-β Signaling

doi:10.1006/mcbr.2001.0301

Molecular Cell Biology Research Communications

Volume 4, Issue 6, November 2001, Pages 321-330

https://doi.org/10.1006/mcbr.2001.0301 Get rights and content

Abstract

Members of transforming growth factor β (TGF-β) family are potent regulators of multiple cellular functions, including cell proliferation, differentiation, migration, organization, and death. Yet the signaling pathways underpinning a wide array of biological activities of TGF-β appear to be deceptively simple. At every step from TGF-β secretion to activation of its target genes, the activity of TGF-β is regulated tightly, both positively and negatively. Biologically active TGF-β is cleaved from a precursor protein (latent form) and multiple process factors control the levels of active TGF-β. The efficient secretion, correct folding and deposition to the extracellular matrices require the cosecretion of latent TGF-β binding proteins (LTBPs). Once activated, TGF-β ligand signals through a heteromeric receptor complex of two distinct type I and type II serine/threonine kinase receptors TβRI and TβRII. Many factors appear to influence the formation of the active ligand–receptor complex. The relative orientation of TβRI and TβRII in the ligand–receptor complex is critical for activation: through TβRI, the activated ligand–receptor complex directly binds and phosphorylates downstream intracellular substrates, called Smads. Inhibitory Smads, Smad6 and 7, can antagonize this process. The phosphorylation of Smads leads to the formation of complexes which translocate to the nucleus. Other signaling systems can modulate the activity of the Smads: e.g., ras activity can prevent Smad complexes from entering the nucleus and specific ubiquitin ligases can target Smad for degradation. In the nucleus, the Smad complexes associate with other transcription activators or suppressors to regulate gene expression, either positively or negatively. The combined effects of the positive and/or negative TGF-β controlled gene expression together with the endogenous protein set of the target cell are responsible for the multiplicity of biological functions.

References (109)

K. Miyazono et al.
J. Biol. Chem.
(1988)
J. Saharinen et al.
Cytokine Growth Factor Rev.
(1999)
K. Miyazono et al.
J Biol. Chem.
(1992)
N.O. Fortunel et al.
Blood
(2000)
S.E. Crawford et al.
Cell
(1998)
J.S. Munger et al.
Cell
(1999)
C. Soo et al.
Am. J. Pathol.
(2000)
M.D. O'Connor-McCourt et al.
J. Biol. Chem.
(1987)
J.J. Lysiak et al.
J. Biol. Chem.
(1995)
A.M. Weaver et al.
J. Biol. Chem.
(1995)

Cited by (97)

TGF-β1 contributes to the hepatic inflammation in animal models with nonalcoholic steatohepatitis by Smad3/TLR2 signaling pathway
2022, Molecular Immunology
Non-alcoholic fatty liver disease (NAFLD) is increasingly affecting human health and the economy worldwide due to various factors. Here, we found that the expression of TGF-β1 and TLR2 was significantly up-regulated in liver samples from both rats and mice nonalcoholic steatohepatitis (NASH) models. By constructing corresponding cell model, we found that TGF-β1 challenge can positively regulate the expression of TLR2 and p-Smad2/3, and the dual luciferase reporter gene system and EMSA assay confirmed the existence of Smad3 binding site (−916 ∼ −906) in the promoter region of TLR2. The overexpression and interference changes of Smad2/3 further verified the above experimental results. Taken together, these findings suggest that TGF-β1 promotes TLR2 transcription and its target gene expression via Smad3, leading to malignant exacerbation of liver inflammation in NASH, which provides new insights into the treatment of NASH.
TGF-β1 promotes hyaluronan synthesis by upregulating hyaluronan synthase 2 expression in human granulosa-lutein cells
2019, Cellular Signalling
Hyaluronan serves as a structural component of ovarian follicles, and hyaluronan-mediated signaling cascades lead to follicular development, oocyte maturation, and ovulation. Transforming growth factor-β (TGF-β1) is highly expressed in human oocytes and granulosa cells and involved in the regulation of follicular development and ovulation. Previous studies have shown the imperative role for TGF-β signaling in the regulation of hyaluronan-mediated cumulus expansion and ovulation in human granulosa-lutein (hGL) cells. However, the detailed underlying molecular mechanisms by which TGF-β regulates the synthesis of hyaluronan in hGL cells are not fully elucidated. Using both primary and immortalized hGL cells as study models, we provide the first data showing that TGF-β1 significantly promoted the synthesis of hyaluronan by upregulating the expression of hyaluronan synthase 2 in these cells. Additionally, using dual inhibition approaches, we show that the TGF-β type II (TβRII) receptor and TGF-β type I (ALK5) receptor are functional receptors that mediate stimulatory effects in response to TGF-β1. Moreover, we found that the canonical SMAD2/SMAD3-SMAD4 signaling pathway is the principal intracellular signaling pathway that upregulates the expressionhyaluronan synthase and subsequent hyaluronan synthesis. Notably, we showed that SNAIL transcription factor is a critical molecule mediating the TGF-β signaling, which contributes to the increase in hyaluronan synthesis. These results of our in vitro studies suggest that intraovarian TGF-β1 plays a functional role in the local regulation of hyaluronan synthesis in hGL cells.
ERK1/2 signaling is required for the initiation but not progression of TGFβ-induced lens epithelial to mesenchymal transition (EMT)
2017, Experimental Eye Research
Transforming Growth Factor Beta (TGFβ) potently induces lens epithelial to mesenchymal transition (EMT). The resultant mesenchymal cells resemble those found in plaques of human forms of subcapsular cataract. Smad signaling has long been implicated as the sole driving force of TGFβ-mediated activity. Rat lens epithelial explants were used to examine the role of the Smad-independent signaling, namely the MAPK/ERK1/2 signaling pathway, in the initiation and progression of TGFβ-induced EMT. Phase contrast microscopy was used to observe the morphological changes associated with TGFβ-induced EMT in this model, including cell elongation, cell membrane blebbing, cell loss as indicated by the area of bare capsule and capsular wrinkling. The levels of Smad2, Smad2/3 and ERK1/2 phosphorylation measured using western blotting confirmed that the addition of UO126 was sufficient in blocking all TGFβ-induced ERK1/2 activation, as well as reducing Smad signaling at 18 h. Immunofluorescent labeling and further western blotting confirmed that TGFβ-induced EMT was associated with an increase in α-smooth muscle actin (α-SMA) and a reduction of E-cadherin at cell borders. Pre-treatment with UO126 was effective at blocking the TGFβ-induced EMT, as evidenced by a reduction of α-SMA expression and protein labeling, E-cadherin labeling at cell borders, and a reduction of cell loss, cell elongation and capsular wrinkling. Post-treatment with UO126 at 2 and 6 h after TGFβ addition was also effective at blocking EMT while post-treatment with UO126 at 24 and 48 h was not sufficient in hampering TGFβ-induced EMT. Our data implicates ERK1/2 signaling in the initiation but not the progression of TGFβ-induced EMT in rat lens epithelial cells. The tight regulation of intracellular signaling pathways such as ERK1/2 are required for the maintenance of lens epithelial cell integrity and hence tissue transparency. A greater understanding of the molecular mechanisms that drive the induction and progression of EMT in the lens will provide the basis for potential therapeutics for human cataract.
SPSB1, a novel negative regulator of the transforming growth factor-β signaling pathway targeting the type II receptor
2015, Journal of Biological Chemistry
Citation Excerpt :
TGF-β signaling is tightly regulated at multiple levels both in and outside the target cells (1): both Lap and Ltbp facilitate secretion of TGF-β while retaining it in its inactive form at the basal state (14, 15); secreted molecules, such as decorin, bind directly to TGF-β ligands and neutralize their biological activity (16, 17); the transmembrane protein BAMBI sequesters ligand from binding to TβRI (18); Dapper2 promotes TβRI degradation (19); Fkbp12 blocks TβRI phosphorylation (20); TmepaI sequesters R-Smads from TβRI kinase activation (21); the E3 ubiquitin ligase Smurf1 degrades R-Smads (22) and Smad7-associated TβRI (23); and Smad7 directly competes with Smad2/3 for binding to TβRI (24). The negative regulator Smad7 is itself negatively regulated by Arkadia through ubiquitination and degradation (1). In the nucleus, transcriptional suppressors negatively regulate the transcriptional activity of the Smad complexes (25).
Appropriate cellular signaling is essential to control cell proliferation, differentiation, and cell death. Aberrant signaling can have devastating consequences and lead to disease states, including cancer. The transforming growth factor-β (TGF-β) signaling pathway is a prominent signaling pathway that has been tightly regulated in normal cells, whereas its deregulation strongly correlates with the progression of human cancers. The regulation of the TGF-β signaling pathway involves a variety of physiological regulators. Many of these molecules act to alter the activity of Smad proteins. In contrast, the number of molecules known to affect the TGF-β signaling pathway at the receptor level is relatively low, and there are no known direct modulators for the TGF-β type II receptor (TβRII). Here we identify SPSB1 (a Spry domain-containing Socs box protein) as a novel regulator of the TGF-β signaling pathway. SPSB1 negatively regulates the TGF-β signaling pathway through its interaction with both endogenous and overexpressed TβRII (and not TβRI) via its Spry domain. As such, TβRII and SPSB1 co-localize on the cell membrane. SPSB1 maintains TβRII at a low level by enhancing the ubiquitination levels and degradation rates of TβRII through its Socs box. More importantly, silencing SPSB1 by siRNA results in enhanced TGF-β signaling and migration and invasion of tumor cells.
Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract
2014, Experimental Eye Research
Cataract is a common age-related condition that is caused by progressive clouding of the normally clear lens. Cataract can be effectively treated by surgery; however, like any surgery, there can be complications and the development of a secondary cataract, known as posterior capsule opacification (PCO), is the most common. PCO is caused by aberrant growth of lens epithelial cells that are left behind in the capsular bag after surgical removal of the fiber mass. An epithelial-to-mesenchymal transition (EMT) is central to fibrotic PCO and forms of fibrotic cataract, including anterior/posterior polar cataracts. Transforming growth factor β (TGFβ) has been shown to induce lens EMT and consequently research has focused on identifying ways of blocking its action. Intriguingly, recent studies in animal models have shown that EMT and cataract developed when a class of negative-feedback regulators, Sprouty (Spry)1 and Spry2, were conditionally deleted from the lens. Members of the Spry family act as general antagonists of the receptor tyrosine kinase (RTK)-mediated MAPK signaling pathway that is involved in many physiological and developmental processes. As the ERK/MAPK signaling pathway is a well established target of Spry proteins, and overexpression of Spry can block aberrant TGFβ-Smad signaling responsible for EMT and anterior subcapsular cataract, this indicates a role for the ERK/MAPK pathway in TGFβ-induced EMT. Given this and other supporting evidence, a case is made for focusing on RTK antagonists, such as Spry, for cataract prevention. In addition, and looking to the future, this review also looks at possibilities for supplanting EMT with normal fiber differentiation and thereby promoting lens regenerative processes after cataract surgery. Whilst it is now known that the epithelial to fiber differentiation process is driven by FGF, little is known about factors that coordinate the precise assembly of fibers into a functional lens. However, recent research provides key insights into an FGF-activated mechanism intrinsic to the lens that involves interactions between the Wnt-Frizzled and Jagged/Notch signaling pathways. This reciprocal epithelial-fiber cell interaction appears to be critical for the assembly and maintenance of the highly ordered three-dimensional architecture that is central to lens function. This information is fundamental to defining the specific conditions and stimuli needed to recapitulate developmental programs and promote regeneration of lens structure and function after cataract surgery.
Soft-focused extracorporeal shock waves increase the expression of tendon-specific markers and the release of anti-inflammatory cytokines in an adherent culture model of primary human tendon cells
2014, Ultrasound in Medicine and Biology
Citation Excerpt :
In particular, it has been found that mechanical forces regulate the expression of SCX through activation of a TGFβ/Smad-mediated pathway, which acts to maintain the integrity of the ECM. Transforming growth factor β is known to be involved in other phases of tissue healing, such as cell proliferation, cell viability and stimulation of collagen production (Zhu and Burgess 2001). Growth factors are among the most important molecules involved in the healing process, but their specific actions are not well characterized.
Focused extracorporeal shock waves have been found to upregulate the expression of collagen and to initiate cell proliferation in healthy tenocytes and to positively affect the metabolism of tendons, promoting the healing process. Recently, soft-focused extracorporeal shock waves have also been found to have a significant effect on tissue regeneration. However, very few in vitro reports have dealt with the application of this type of shock wave to cells, and in particular, no previous studies have investigated the response of tendon cells to this impulse. We devised an original model to investigate the in vitro effects of soft-focused shock waves on a heterogeneous population of human resident tendon cells in adherent monolayer culture. Our results indicate that soft-focused extracorporeal shock wave treatment (0.17 mJ/mm²) is able to induce positive modulation of cell viability, proliferation and tendon-specific marker expression, as well as release of anti-inflammatory cytokines. This could prefigure a new rationale for routine employment of soft-focused shock waves to treat the failed healing status that distinguishes tendinopathies.

View all citing articles on Scopus

¹: To whom correspondence should be addressed. Fax: +61-3-93413104. E-mail: [email protected].

View full text

MinireviewRegulation of Transforming Growth Factor-β Signaling

Abstract

J. Biol. Chem.

Cytokine Growth Factor Rev.

J Biol. Chem.

Blood

Cell

Cell

Am. J. Pathol.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Exp. Neurol.

J. Biol. Chem.

J. Biol. Chem.

Am. J. Pathol.

Cell

Cell

Cell

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Cell

Chem. Biol.

Cell

Cell

J. Biol. Chem.

Trends Cell Biol.

J. Biol. Chem.

J. Biol. Chem.

J Biol. Chem.

J. Biol. Chem.

Cell

Cell

J. Biol. Chem.

Mol. Cell

Cell

J. Biol. Chem.

Curr. Biol.

Cell

Mol. Cell

Mol. Cell

Cell

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Annu. Rev. Biochem.

Minireview
Regulation of Transforming Growth Factor-β Signaling